Investigation of Acinetobacter baumannii-specific bacteriophage
Öz
Purpose: In recent years, the increasing resistance to antibiotics observed in many important bacterial groups has led to a growing interest in the literature regarding phage isolation and characterization, and the expanding clinical potential of phages. Considering the antimicrobial resistance profiles, the isolation of phages to be used in the treatment of Acinetobacter baumannii infections, determination of their action spectrum and characterization are very important. This study aimed to isolate bacteriophages specific to the target microorganism, A. baumannii, from environmental water sources.
Materials and Methods: Sixteen different environmental water samples were investigated as potential sources of phages. Clinical isolates of A. baumannii with multi-drug resistant were used as the host bacteria. Phages specific to the target bacteria were isolated using a single plaque isolation method. During in vitro studies, the titers of the isolated phages were increased using the double agar method, and their plaque morphology and host specificity were evaluated.
Results: The phage vB_KlAcineto13 exhibited lytic activity exclusively against the target bacterium and did not infect other bacterial isolates.
Conclusion: Based on the findings of this study, it can be concluded that phage vB_KlAcineto13 has a narrow host range and does not infect other tested bacteria outside the host bacterium. However, characterization studies are likely to provide more detailed information about the phage.
Anahtar Kelimeler
Bacteriophage, phage, phage therapy, Acinetobacter baumannii, phage isolation
Destekleyen Kurum
This research was funded by the Kırklareli University Scientific Research Projects Unit (BAP) under project number KLU-BAP-252.
Proje Numarası
This research was funded by the Kırklareli University Scientific Research Projects Unit (BAP) under project number KLU-BAP-252.
Etik Beyan
The author declare no competing interests.
Teşekkür
I’m thankful to Professor Suheyla Turkyilmaz and Erbey Cihan, Microbiology Lab, Faculty of Veterinary Medicine, Aydın Adnan Menderes University for providing bacterial strains.
Kaynakça
- Frieri M, Kumar K, Boutin A. Antibiotic resistance. J. Infect. Public Health. 2017;10:378-69.
- Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 2008;197:1081-79.
- Skurnik M. Can bacteriophages replace antibiotics?. Antibiotics. 2022;11:575.
- Hitchcock NM, Devequi Gomes Nunes D, Shiach J, Valeria Saraiva Hodel K, Dantas Viana Barbosa J, Alencar Pereira Rodrigues L et al. Current clinical landscape and global potential of bacteriophage therapy. Viruses. 2023;15:1020.
- Oduor JM, Onkoba N, Maloba F, Arodi WO, Nyachieo A. Efficacy of lytic Staphylococcus aureus bacteriophage against multidrug-resistant Staphylococcus aureus in mice. J Infect Dev Ctries. 2016;10:1213-08.
- Bao J, Wu N, Zeng Y, Chen L, Li L, Yang L et al. Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Emerg Microbes Infect. 2020;9:774-71.
- Li Y, Xiao S, Huang G. Acinetobacter baumannii bacteriophage: progress in isolation, genome sequencing, preclinical research, and clinical application. Curr. Microbiol. 2023;80:199.
- Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 2011;26:112-101.
- Rao S, Betancourt-Garcia M, Kare-Opaneye YO, Swierczewski BE, Bennett JW, Horne BA et al. Critically ill patient with multidrug-resistant Acinetobacter baumannii respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy. Antimicrob Agents Chemother. 2022;66:e00824-21.
- Badawy S, Pajunen MI, Haiko J, Baka ZA, Abou-Dobara MI, El-Sayed AK et al. Identification and functional analysis of temperate Siphoviridae bacteriophages of Acinetobacter baumannii. Viruses. 2020;12:604.
